Biofrontera Inc. (BFRI): Shareholders' Equity
$10.48M
As of 2025-12-31
$5.96M
As of 2026-06-30
-24.0%
3-year compound annual growth
+12.5%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.48M | +136.4% | 2026-03-19, Balance as of period end |
| 2024-12-31 | $4.43M | -7.5% | 2026-03-19, Balance as of period end |
| 2023-12-31 | $4.79M | -79.9% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $23.88M | +110.6% | 2024-03-15, Balance as of period end |
| 2021-12-31 | $11.34M | +94.5% | 2023-03-13, Balance as of period end |
| 2020-12-31 | $5.83M | n/a | 2022-04-11, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Biofrontera Inc. (BFRI) | 2025-12-31 | $10.48M | +136.4% |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | $518.36M | +147.4% |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | $35.27M | +100.4% |
| Integrated Biopharma Inc (INBP) | 2026-06-30 | $17.67M | -13.0% |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $24.88M | +8.9% |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | -$33.66M | n/m |
| BGM Group Ltd. (BGM) | 2025-09-30 | $391.90M | +788.8% |
| Septerna, Inc. (SEPN) | 2025-12-31 | $381.93M | -9.1% |
| Protagonist Therapeutics, Inc (PTGX) | 2025-12-31 | $614.71M | -9.0% |
Compare BFRI, WVE, XLO, INBP side by side · Screen every company in Pharmaceutical Preparations ↗